Why Compare Wegovy Doses Chart Against Mounjaro?
Wegovy Doses Chart vs Mounjaro: The Complete Dosing Comparison
Understanding the Wegovy doses chart alongside Mounjaro's dosing schedule reveals two fundamentally different approaches to weight management. Wegovy employs a structured 5-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase helps minimise gastrointestinal side effects whilst building therapeutic efficacy. Mounjaro follows a different path with 6 available doses: 2.5mg starting dose, escalating through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum 15mg maintenance dose.
The key difference lies not just in the numbers but in the underlying mechanisms these doses support. Wegovy's doses chart reflects semaglutide's singular focus on GLP-1 receptor activation, requiring precise escalation to achieve optimal appetite suppression and gastric emptying delay. Mounjaro's higher numerical doses reflect tirzepatide's dual action on both GIP and GLP-1 receptors, necessitating different dose ranges to achieve therapeutic benefit. Neither approach is inherently superior – they represent different pharmaceutical strategies for the same clinical goal of supporting weight management alongside diet and exercise.
Pricing Analysis: Wegovy Doses Chart Costs vs Mounjaro Investment
When examining the Wegovy doses chart from a cost perspective, each dose carries specific pricing that reflects the escalating complexity and potency. Our single pen pricing starts with 0.25mg at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, to maintenance 2.4mg at £209.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. The Complete Journey from starter to maintenance represents a significant but structured investment in your weight management goals.
For those preferring convenience and supply security, our bundle options provide strategic value. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of treatment in one order. The Ultimate Stability Trio offers three months of 2.4mg maintenance pens for £649.99, ensuring consistent supply without repeated ordering. These bundles emphasise convenience and Confirmed Availability rather than cost savings – fewer transactions, reduced shipping complexity, and peace of mind regarding supply continuity.
Clinical Evidence Behind the Wegovy Doses Chart Design
The specific doses outlined in the Wegovy doses chart stem from extensive clinical validation through the STEP trial programme. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The dose escalation protocol proved crucial in achieving these outcomes whilst maintaining tolerability across diverse patient populations.
The SELECT cardiovascular outcomes trial further validated the 2.4mg maintenance dose, demonstrating a 20% reduction in major cardiovascular events (HR 0.80) in patients with established cardiovascular disease. This evidence supported the specific dose progression outlined in the Wegovy doses chart, confirming that each escalation step serves both safety and efficacy purposes in real-world clinical application.
How Wegovy's Dosing Schedule Supports Its Mechanism
The Wegovy doses chart reflects semaglutide's action as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone GLP-1 that's released after meals. Each dose increase allows your body to adapt to enhanced GLP-1 activity, which reduces appetite by acting on brain appetite centres and promotes feelings of fullness after smaller meals. The gradual escalation prevents overwhelming your digestive system whilst building therapeutic levels that effectively modulate hunger signals and food cravings. This prescription-only medicine works by slowing gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. The final 2.4mg maintenance dose represents the optimal balance between therapeutic benefit and tolerability for most patients when used alongside a reduced-calorie diet and increased physical activity.
Ordering Process: Getting Your Wegovy Doses Chart Treatment
Accessing treatment following the Wegovy doses chart begins with our streamlined 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our qualified prescribers review your assessment within 3 working days as standard, with express 24-hour review available for urgent cases. Upon approval, we dispatch your Wegovy pens via temperature-controlled, cold-chain next-day delivery to ensure medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door. The process includes comprehensive guidance on proper injection technique, storage requirements, and dose escalation timing to optimise your treatment outcome. Our clinical team remains available throughout your treatment journey to address questions about progressing through the Wegovy doses chart safely and effectively.
Storage and Practical Considerations in the Wegovy Doses Chart vs Mounjaro Debate
Understanding storage requirements becomes crucial when following either the Wegovy doses chart or Mounjaro's dosing protocol, particularly for those with active lifestyles or frequent travel. Wegovy pens must be stored in the fridge at 2-8°C before first use but offer exceptional travel flexibility, remaining stable at room temperature below 30°C for up to 6 weeks once removed from refrigeration. This contrasts favourably with Mounjaro's 21-day room temperature limit, potentially making Wegovy more suitable for extended business travel or holidays. Both medications use pre-filled FlexTouch pen devices for convenient once-weekly injection, but the longer room temperature tolerance of Wegovy provides practical advantages for maintaining consistent dosing schedules regardless of circumstances.
Wegovy Doses Chart Escalation Strategy vs Mounjaro's Titration Approach
The philosophy behind the Wegovy doses chart reveals a conservative, evidence-based escalation strategy designed to balance efficacy with tolerability. Starting at 0.25mg allows patients to adapt gradually to GLP-1 receptor activation, with each 4-week period providing sufficient time to assess tolerance before progression. This contrasts with Mounjaro's approach, which begins at 2.5mg – a higher starting point reflecting tirzepatide's different receptor binding profile and pharmacokinetics. Neither approach is superior; they reflect distinct pharmaceutical designs optimised for their respective active compounds.
The Wegovy doses chart's structured progression means patients experience a predictable journey with clear milestones, making it easier to anticipate costs and plan supply needs. Each dose increase represents a deliberate step toward the therapeutic target, with built-in flexibility for patients who need slower progression due to side effects. This systematic approach, validated through clinical trials, provides both patients and prescribers with confidence in the treatment pathway from initiation through maintenance dosing.
Making Your Choice: Both Available Through EverydayMeds
Rather than declaring one medication superior, we recognise that both Wegovy and Mounjaro offer valuable options for different patient needs and preferences. The Wegovy doses chart appeals to those preferring gradual escalation and proven GLP-1 therapy, whilst Mounjaro's dual-hormone approach may suit patients seeking alternative mechanisms or those who haven't achieved desired outcomes with GLP-1-only treatments. As a GPhC-registered pharmacy (#9012878), EverydayMeds uniquely offers both medications, allowing your prescriber to select the most appropriate option based on your individual circumstances, medical history, and treatment goals. Use code FIRST40 for new customers or DOSE25 for returning customers at checkout, with both medications available for next-day delivery following clinical approval. Our clinical team's expertise ensures you receive comprehensive support regardless of which prescription-only medicine pathway you and your prescriber choose for your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
